Petter Bjornstad1, David M Maahs2, Lindsey M Duca3, Laura Pyle4, Marian Rewers5, Richard J Johnson6, Janet K Snell-Bergeon5. 1. Department of Pediatric Endocrinology, University of Colorado School of Medicine, Aurora, CO; Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO. Electronic address: Petter.Bjornstad@childrenscolorado.org. 2. Department of Pediatric Endocrinology, University of Colorado School of Medicine, Aurora, CO; Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO; Department of Nephrology, University of Colorado Denver, Aurora, CO. 3. Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO; Colorado School of Public Health, University of Colorado Denver, Aurora, CO. 4. Department of Pediatric Endocrinology, University of Colorado School of Medicine, Aurora, CO. 5. Department of Pediatric Endocrinology, University of Colorado School of Medicine, Aurora, CO; Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, CO. 6. Department of Nephrology, University of Colorado Denver, Aurora, CO.
Abstract
OBJECTIVE: Reduced insulin sensitivity (IS) is well documented in type 1 diabetes (T1D) and may contribute to vascular complications. We examined the association of estimated IS (eIS) with incident macro- and microvascular complications in adults with T1D in the prospective CACTI study. METHODS: Participants (N=652) were 19-56 years old at baseline and re-examined 6.2±0.6years later. Urinary albumin excretion was measured, and categorized as microalbuminuria or greater. Diabetic retinopathy (DR) was based on self-reported history, proliferative DR (PDR) as history of laser eye therapy and coronary artery calcium (CAC) was measured using electron-beam CT. Progression of CAC was defined as a change in the square root transformed CAC volume score of ≥2.5. IS was estimated (eIS) by an equation derived from clamp studies. Predictors of each complication were examined using stepwise logistic regression and subjects with complications at baseline excluded. Age, T1D duration, sex, HbA1c, SBP, LDL-C, and eIS were considered for inclusion. RESULTS: Greater eIS at baseline predicted lower odds of developing albuminuria (OR: 0.67, 95% CI 0.51-0.88), DR (OR 0.79, 0.64-0.97), PDR (OR: 0.76, 0.57-0.99) and CACp (OR: 0.71, 0.60-0.85) in multivariable models. CONCLUSIONS: Greater eIS conferred protection from the development of vascular complications over 6-years in T1D.
OBJECTIVE: Reduced insulin sensitivity (IS) is well documented in type 1 diabetes (T1D) and may contribute to vascular complications. We examined the association of estimated IS (eIS) with incident macro- and microvascular complications in adults with T1D in the prospective CACTI study. METHODS:Participants (N=652) were 19-56 years old at baseline and re-examined 6.2±0.6years later. Urinary albumin excretion was measured, and categorized as microalbuminuria or greater. Diabetic retinopathy (DR) was based on self-reported history, proliferative DR (PDR) as history of laser eye therapy and coronary artery calcium (CAC) was measured using electron-beam CT. Progression of CAC was defined as a change in the square root transformed CAC volume score of ≥2.5. IS was estimated (eIS) by an equation derived from clamp studies. Predictors of each complication were examined using stepwise logistic regression and subjects with complications at baseline excluded. Age, T1D duration, sex, HbA1c, SBP, LDL-C, and eIS were considered for inclusion. RESULTS: Greater eIS at baseline predicted lower odds of developing albuminuria (OR: 0.67, 95% CI 0.51-0.88), DR (OR 0.79, 0.64-0.97), PDR (OR: 0.76, 0.57-0.99) and CACp (OR: 0.71, 0.60-0.85) in multivariable models. CONCLUSIONS: Greater eIS conferred protection from the development of vascular complications over 6-years in T1D.
Authors: Donald S Fong; Lloyd Aiello; Thomas W Gardner; George L King; George Blankenship; Jerry D Cavallerano; Fredrick L Ferris; Ronald Klein Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Peter Libby; David M Nathan; Kristin Abraham; John D Brunzell; Judith E Fradkin; Steven M Haffner; Willa Hsueh; Marian Rewers; B Tibor Roberts; Peter J Savage; Sonia Skarlatos; Momtaz Wassef; Cristina Rabadan-Diehl Journal: Circulation Date: 2005-06-28 Impact factor: 29.690
Authors: Lena M Thorn; Carol Forsblom; Johan Fagerudd; Merlin C Thomas; Kim Pettersson-Fernholm; Markku Saraheimo; Johan Wadén; Mats Rönnback; Milla Rosengård-Bärlund; Clas-Göran Af Björkesten; Marja-Riitta Taskinen; Per-Henrik Groop Journal: Diabetes Care Date: 2005-08 Impact factor: 19.112
Authors: David M Maahs; Gregory L Kinney; Paul Wadwa; Janet K Snell-Bergeon; Dana Dabelea; John Hokanson; James Ehrlich; Satish Garg; Robert H Eckel; Marian J Rewers Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112
Authors: Janet K Snell-Bergeon; John E Hokanson; Lisa Jensen; Todd MacKenzie; Gregory Kinney; Dana Dabelea; Robert H Eckel; James Ehrlich; Satish Garg; Marian Rewers Journal: Diabetes Care Date: 2003-10 Impact factor: 19.112
Authors: Michael A Grassi; D Anthony Mazzulla; Michael D Knudtson; Wendy W Huang; Kristine E Lee; Barbara E Klein; Dan L Nicolae; Ronald Klein Journal: Am J Ophthalmol Date: 2008-12-03 Impact factor: 5.258
Authors: Bruce A Perkins; Linda H Ficociello; Kristen H Silva; Dianne M Finkelstein; James H Warram; Andrzej S Krolewski Journal: N Engl J Med Date: 2003-06-05 Impact factor: 91.245
Authors: Petter Bjornstad; Michal Schäfer; Uyen Truong; Melanie Cree-Green; Laura Pyle; Amy Baumgartner; Yesenia Garcia Reyes; Aristides Maniatis; Sunil Nayak; R Paul Wadwa; Lorna P Browne; Jane E B Reusch; Kristen J Nadeau Journal: Circulation Date: 2018-12-18 Impact factor: 29.690
Authors: Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Genevieve Boulet; Leif E Lovblom; Omar N Alhuzaim; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney Journal: Diabetes Care Date: 2018-02-02 Impact factor: 19.112
Authors: Petter Bjornstad; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Yesenia Garcia Reyes; Michal Schafer; Laura Pyle; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau Journal: J Diabetes Complications Date: 2017-03-14 Impact factor: 2.852
Authors: Kalie L Tommerdahl; Petter Bjornstad; Jessica Kendrick; Melanie Cree-Green; Amy D Baumgartner; Laura Pyle; Jane E B Reusch; Kristen J Nadeau Journal: Diabetes Obes Metab Date: 2020-12-23 Impact factor: 6.577
Authors: Kaitlin M Love; Linda A Jahn; Lee M Hartline; James T Patrie; Eugene J Barrett; Zhenqi Liu Journal: Sci Rep Date: 2021-06-01 Impact factor: 4.379